Cargando…

Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates

Detalles Bibliográficos
Autores principales:	Moog, C, Dereuddre-Bosquet, N, Biedma, M, Schmidt, S, Decoville, T, Mangeot, I, Zolla-Pazner, S, Vcelar, B, Katinger, D, Holl, V, Le Grand, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441560/ http://dx.doi.org/10.1186/1742-4690-9-S2-O38

Ejemplares similares

Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
por: Mayr, Luzia M., et al.
Publicado: (2017)

Targeting HIV Gag p24 to DICR on dendritic cells induces T cell and potent and long-lasting antibody responses in non-human primates
por: Flamar, A, et al.
Publicado: (2012)

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection
por: Lederle, A, et al.
Publicado: (2009)

Pharmacological Validation of Long-Term Treatment with Antiretroviral Drugs in a Model of SIV-Infected Non-Human Primates
por: Gelé, Thibaut, et al.
Publicado: (2022)

P04-27. Monoclonal neutralizing antibodies inhibit HIV-1 transfer from immature dendritic cells to human primary CD4 T-lymphocytes
por: Xu, K, et al.
Publicado: (2009)

Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies
por: Frey, Gary, et al.
Publicado: (2010)

Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates
por: Bekri, Selma, et al.
Publicado: (2017)

Mucosal application of the broadly neutralizing antibody 10-1074 protects macaques from cell-associated SHIV vaginal exposure
por: Suphaphiphat, Karunasinee, et al.
Publicado: (2023)

Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates
por: Bayon, Emilie, et al.
Publicado: (2018)

Neutralizing Antibodies Inhibit HIV-1 Infection of Plasmacytoid Dendritic Cells by an FcγRIIa Independent Mechanism and Do Not Diminish Cytokines Production
por: Lederle, Alexandre, et al.
Publicado: (2014)

Impact of IgG Isotype on the Induction of Antibody-Dependent Cellular Phagocytosis of HIV by Human Milk Leukocytes
por: Fox, Alisa, et al.
Publicado: (2022)

P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells
por: Delaporte, M, et al.
Publicado: (2009)

Towards a vaccine against AIDS
por: Vieillard, Vincent, et al.
Publicado: (2010)

Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates
por: Marc, Aurélien, et al.
Publicado: (2023)

P11-16. Transfer of HIV-1 from Langerhans and interstitial dendritic cells to T lymphocytes: protection mediated by antibodies?
por: Peressin, M, et al.
Publicado: (2009)

A Temperature-Monitoring Vaginal Ring for Measuring Adherence
por: Boyd, Peter, et al.
Publicado: (2015)

P19-26. Directing macaque immune responses with an anti-dendritic cell HIV Gag p24 fusion protein vaccine
por: Martinon, F, et al.
Publicado: (2009)

Comparative Magnitude of Cross-Strain Conservation of HIV Variable Loop Neutralization Epitopes
por: Swetnam, James, et al.
Publicado: (2010)

Sotrovimab retains activity against SARS-CoV-2 omicron variant BQ.1.1 in a non-human primate model
por: Hérate, Cécile, et al.
Publicado: (2023)

OA05-03. Efficacy study of a T-cell-based DNA vaccine delivered by intradermal electrotransfer in macaques
por: Dereuddre-Bosquet, N, et al.
Publicado: (2009)

SARS-CoV-2 viral dynamics in non-human primates
por: Gonçalves, Antonio, et al.
Publicado: (2021)

Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
por: Alexandre, Marie, et al.
Publicado: (2022)

Pharmacokinetic comparison of a diverse panel of non-targeting human antibodies as matched IgG1 and IgG2 isotypes in rodents and non-human primates
por: Walker, Kenneth W., et al.
Publicado: (2019)

Broadly neutralizing humanized SARS-CoV-2 antibody binds to a conserved epitope on Spike and provides antiviral protection through inhalation-based delivery in non-human primates
por: Hermet, Paule, et al.
Publicado: (2023)

Broadly neutralizing antibodies potently inhibit cell-to-cell transmission of semen leukocyte-derived SHIV162P3
por: Suphaphiphat, Karunasinee, et al.
Publicado: (2020)

Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates
por: Vonarburg, Cédric, et al.
Publicado: (2019)

Non-Neutralizing Antibodies Directed against HIV and Their Functions
por: Mayr, Luzia M., et al.
Publicado: (2017)

Alterations of HIV-1 envelope phenotype and antibody-mediated neutralization by signal peptide mutations
por: Upadhyay, Chitra, et al.
Publicado: (2018)

Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines
por: Weiss, Svenja, et al.
Publicado: (2022)

A novel adjuvant formulation induces robust Th1/Th17 memory and mucosal recall responses in Non-Human Primates
por: Woodworth, Joshua S, et al.
Publicado: (2023)

Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
por: Marlin, Romain, et al.
Publicado: (2022)

Identifying epitopes of HIV-1 that induce protective antibodies
por: Zolla-Pazner, Susan
Publicado: (2004)

High-resolution crystal structure of the Fv of quaternary neutralizing epitope mAb 2909 reveals atomic details of its antigen-binding site
por: Sampson, JM, et al.
Publicado: (2012)

P04-55 LB. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
por: Zolla-Pazner, S, et al.
Publicado: (2009)

Focusing the immune response on the V3 loop of HIV-1 gp120 induces cross-clade neutralizing
por: Zolla-Pazner, Susan, et al.
Publicado: (2006)

The Frequencies of Immunosuppressive Cells in Adipose Tissue Differ in Human, Non-human Primate, and Mouse Models
por: Laparra, Ariane, et al.
Publicado: (2019)

Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model
por: Lorenzen, Emma, et al.
Publicado: (2022)

The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time
por: Fox, Alisa, et al.
Publicado: (2022)

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope
por: Zolla-Pazner, S, et al.
Publicado: (2009)

Fully Human Monoclonal Antibody Inhibitors of the Neonatal Fc Receptor Reduce Circulating IgG in Non-Human Primates
por: Nixon, Andrew E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jaakbp1n0d9jkf8mdnhdj7jkgr